Robert Van den Heuvel

Robert van den Heuvel, PhD is a biotech executive and consultant with over 20 years of experience in Quality, CMC, and operations across biologics and ATMPs. He is a Managing Consultant at AspireBio Consulting, where he supports biotech companies in building phase appropriate, inspection ready Quality and CMC frameworks from early development through commercialization. Robert has held senior Quality and operational leadership roles in both sponsor and CDMO organizations across North America and Europe. His expertise spans Quality systems, GMP compliance, regulatory inspections, tech transfer, and manufacturing scale up for cell therapies, viral vectors, and complex biologics. He is particularly recognized for integrating Quality early into development to enable speed, comparability, and long term manufacturing sustainability. Robert combines deep scientific understanding with pragmatic Quality and operational execution. He is known for translating regulatory expectations into scalable, risk based strategies that support innovation while maintaining compliance and product quality.